Indeed, MNs of patients with ALS, derived from the differentiation of induced pluripotent stem cells, were found to express the receptor for IL-17A (IL-17AR), and they were vulnerable to its neurotoxic action in a dose-dependent manner; however, they were not damaged by exposure to IL-17F. The gene discussed is IL17A; the disease is amyotrophic lateral sclerosis.